LGHT vs. GNOM ETF Comparison
Comparison of Langar Global HealthTech ETF (LGHT) to Global X Genomics & Biotechnology ETF (GNOM)
LGHT
Langar Global HealthTech ETF
LGHT Description
LGHT targets the global healthcare technology industry. The fund actively invests in HealthTech companies, which the adviser defines as firms that develop technology designed to create healthcare efficiency by addressing key pain points for patients, providers, payors, and hospitals, including those companies that derive a majority of their revenue from HealthTech products and services. The portfolio construction starts by identifying companies that fit into the advisers HealthTech definition. The remaining companies are screened using a proprietary metric that assesses each firms financial health, involvement in relevant controversies, as well as the strength of its team and culture. Each company is then assigned an industry risk score through an algorithm that defines quantitative and qualitative risk categories and weights them accordingly. Finally, each company is reviewed by an investment committee. However, the portfolio manager still has full discretion over the final selection.
Grade (RS Rating)
Last Trade
$10.42
Average Daily Volume
913
31
GNOM
Global X Genomics & Biotechnology ETF
GNOM Description
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.Grade (RS Rating)
Last Trade
$10.08
Average Daily Volume
43,573
40
Performance
| Period | LGHT | GNOM |
|---|---|---|
| 30 Days | -0.59% | -5.26% |
| 60 Days | -1.40% | -8.86% |
| 90 Days | -1.14% | -12.73% |
| 12 Months | -3.58% |
LGHT Overweight 29 Positions Relative to GNOM
| Symbol | Grade | Weight | |
|---|---|---|---|
| ISRG | A | 15.39% | |
| GEHC | F | 8.56% | |
| RMD | C | 6.71% | |
| IQV | D | 6.34% | |
| DXCM | D | 5.51% | |
| PODD | C | 5.26% | |
| VEEV | C | 5.15% | |
| PHG | D | 4.87% | |
| ZBH | C | 3.57% | |
| ALGN | D | 2.85% | |
| MASI | A | 2.46% | |
| DOCS | C | 2.06% | |
| PRCT | B | 1.27% | |
| ALKS | B | 0.66% | |
| TNDM | F | 0.54% | |
| IRTC | D | 0.44% | |
| PRVA | B | 0.44% | |
| OMCL | C | 0.42% | |
| LFST | C | 0.31% | |
| TDOC | C | 0.28% | |
| PGNY | F | 0.25% | |
| EVH | F | 0.22% | |
| SDGR | C | 0.21% | |
| GDRX | F | 0.2% | |
| ALHC | C | 0.2% | |
| PHR | F | 0.17% | |
| ACCD | D | 0.07% | |
| MODV | C | 0.03% | |
| TBRG | B | 0.03% |
LGHT Underweight 38 Positions Relative to GNOM
| Symbol | Grade | Weight | |
|---|---|---|---|
| NTRA | B | -6.14% | |
| VCYT | B | -5.24% | |
| CRSP | D | -4.45% | |
| QGEN | D | -4.33% | |
| TECH | D | -4.3% | |
| A | D | -4.19% | |
| RNA | D | -4.17% | |
| ARWR | F | -4.07% | |
| ILMN | D | -3.99% | |
| LEGN | F | -3.96% | |
| BMRN | D | -3.88% | |
| SRPT | D | -3.7% | |
| RARE | D | -3.68% | |
| ALNY | D | -3.66% | |
| BEAM | D | -3.6% | |
| MYGN | F | -2.74% | |
| TXG | F | -2.72% | |
| NTLA | F | -2.69% | |
| CDNA | D | -2.27% | |
| RCKT | F | -2.24% | |
| GILD | C | -2.2% | |
| VRTX | F | -2.08% | |
| VIR | D | -1.22% | |
| MRVI | F | -1.15% | |
| PACB | F | -0.91% | |
| RGNX | F | -0.87% | |
| SGMO | C | -0.79% | |
| FLGT | F | -0.69% | |
| SANA | F | -0.62% | |
| VERV | F | -0.58% | |
| ALLO | F | -0.57% | |
| QURE | D | -0.52% | |
| EDIT | F | -0.4% | |
| PSTX | D | -0.36% | |
| CRBU | F | -0.33% | |
| TSVT | F | -0.3% | |
| LYEL | F | -0.29% | |
| SCLX | F | -0.01% |
LGHT: Top Represented Industries & Keywords
GNOM: Top Represented Industries & Keywords
Compare ETFs
